Functional signaling of membrane-bound TL1A induces IFN-γ expression

FEBS Letters

Volumn 584, Issue 11, 2010, Pages 2376-2380

  Biener Ramanujan, Eva ^a   Gonsky, Rivkah ^a   Ko, Brian ^a   Targan, Stephan R ^a  

^a CEDARS SINAI MEDICAL CENTER   (United States)

Author keywords

Death domain receptor 3; IFN ; Membrane bound TL1A; TL1A signaling

Indexed keywords

DEATH RECEPTOR 3; GAMMA INTERFERON; INTERLEUKIN 12; INTERLEUKIN 18; PROTEIN ANTIBODY; PROTEIN TL1A; TUMOR NECROSIS FACTOR; UNCLASSIFIED DRUG;

ARTICLE; CD4+ T LYMPHOCYTE; CELL CONTACT; CELL STRAIN HEK293; CONTROLLED STUDY; CYTOKINE PRODUCTION; CYTOKINE RELEASE; FLOW CYTOMETRY; HUMAN; HUMAN CELL; IMMUNOPATHOLOGY; PRIORITY JOURNAL; PROTEIN BINDING; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN PROTEIN INTERACTION;

CELLULAR STRUCTURES; INTERLEUKIN-12; INTERLEUKIN-18; RECEPTORS, TUMOR NECROSIS FACTOR, MEMBER 25; SIGNAL TRANSDUCTION; T-LYMPHOCYTES;

EID: 77952893051     PISSN: 00145793     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.febslet.2010.04.030     Document Type: Article

References (23)

1. Migone T.S., et al. TL1A is a TNF-like ligand for DR3 and TR6/DcR3 and functions as a T cell costimulator. Immunity 2002, 16:479-492.
2. Bull M.J., et al. The Death Receptor 3-TNF-like protein 1A pathway drives adverse bone pathology in inflammatory arthritis. J. Exp. Med. 2008, 205:2457-2464.
3. Bamias G., Siakavellas S.I., Stamatelopoulos K.S., Chryssochoou E., Papamichael C., Sfikakis P.P. Circulating levels of TNF-like cytokine 1A (TL1A) and its decoy receptor 3 (DcR3) in rheumatoid arthritis. Clin. Immunol. 2008, 129:249-255.
4. Zhang J., Wang X., Fahmi H., Wojcik S., Fikes J., Yu Y., Wu J., Luo H. Role of TL1A in the pathogenesis of rheumatoid arthritis. J. Immunol. 2009, 183:5350-5357.
5. Meylan F., et al. The TNF-family receptor DR3 is essential for diverse T cell-mediated inflammatory diseases. Immunity 2008, 29:79-89.
6. Pappu B.P., et al. TL1A-DR3 interaction regulates Th17 cell function and Th17-mediated autoimmune disease. J. Exp. Med. 2008, 205:1049-1062.
7. Fang L., Adkins B., Deyev V., Podack E.R. Essential role of TNF receptor superfamily 25 (TNFRSF25) in the development of allergic lung inflammation. J. Exp. Med. 2008, 205:1037-1048.
8. Takedatsu H., Michelsen K.S., Wei B., Landers C.J., Thomas L.S., Dhall D., Braun J., Targan S.R. TL1A (TNFSF15) regulates the development of chronic colitis by modulating both T-helper 1 and T-helper 17 activation. Gastroenterology 2008, 135:552-567.
9. Michelsen K.S., et al. IBD-associated TL1A gene (TNFSF15) haplotypes determine increased expression of TL1A protein. PLoS One 2009, 4:e4719.
10. Bamias G., et al. Expression, localization, and functional activity of TL1A, a novel Th1-polarizing cytokine in inflammatory bowel disease. J. Immunol. 2003, 171:4868-4874.
11. Kamada N., et al. TL1A produced by lamina propria macrophages induces Th1 and Th17 immune responses in cooperation with IL-23 in patients with Crohn's disease. Inflamm. Bowel Dis. 2010, 16:568-575.
12. Prehn J.L., Mehdizadeh S., Landers C.J., Luo X., Cha S.C., Wei P., Targan S.R. Potential role for TL1A, the new TNF-family member and potent costimulator of IFN-gamma, in mucosal inflammation. Clin. Immunol. 2004, 112:66-77.
13. Papadakis K.A., Zhu D., Prehn J.L., Landers C., Avanesyan A., Lafkas G., Targan S.R. Dominant role for TL1A/DR3 pathway in IL-12 plus IL-18-induced IFN-gamma production by peripheral blood and mucosal CCR9+ T lymphocytes. J. Immunol. 2005, 174:4985-4990.
14. Bamias G., Mishina M., Nyce M., Ross W.G., Kollias G., Rivera-Nieves J., Pizarro T.T., Cominelli F. Role of TL1A and its receptor DR3 in two models of chronic murine ileitis. Proc. Natl. Acad. Sci. USA 2006, 103:8441-8446.
15. Prehn J.L., Thomas L.S., Landers C.J., Yu Q.T., Michelsen K.S., Targan S.R. The T cell costimulator TL1A is induced by FcgammaR signaling in human monocytes and dendritic cells. J. Immunol. 2007, 178:4033-4038.
16. Cassatella M.A., et al. Soluble TNF-like cytokine (TL1A) production by immune complexes stimulated monocytes in rheumatoid arthritis. J. Immunol. 2007, 178:7325-7333.
17. Shih D.Q., et al. Microbial induction of inflammatory bowel disease associated gene TL1A (TNFSF15) in antigen presenting cells. Eur. J. Immunol. 2009, 39:3239-3250.
18. Bodmer J.L., Schneider P., Tschopp J. The molecular architecture of the TNF superfamily. Trends Biochem. Sci. 2002, 27:19-26.
19. Chen Y., et al. Mutations within a furin consensus sequence block proteolytic release of ectodysplasin-A and cause X-linked hypohidrotic ectodermal dysplasia. Proc. Natl. Acad. Sci. USA 2001, 98:7218-7223.
20. Schneider P., et al. Mutations leading to X-linked hypohidrotic ectodermal dysplasia affect three major functional domains in the tumor necrosis factor family member ectodysplasin-A. J. Biol. Chem. 2001, 276:18819-18827.
21. Lopez-Fraga M., Fernandez R., Albar J.P., Hahne M. Biologically active APRIL is secreted following intracellular processing in the Golgi apparatus by furin convertase. EMBO Rep. 2001, 2:945-951.
22. Schneider P., et al. BAFF, a novel ligand of the tumor necrosis factor family, stimulates B cell growth. J. Exp. Med. 1999, 189:1747-1756.
23. Papadakis K.A., Prehn J.L., Landers C., Han Q., Luo X., Cha S.C., Wei P., Targan S.R. TL1A synergizes with IL-12 and IL-18 to enhance IFN-gamma production in human T cells and NK cells. J. Immunol. 2004, 172:7002-7007.